That is not to say if you looked and the R&D for a
Post# of 148380
(Total Views: 432)
Posted On: 08/20/2019 6:14:37 PM
That is not to say if you looked and the R&D for a particular drug it would be $3B. The total cost/each approved drug, how much BP is spending amortized per approved drug.
The actual cost of the drug is less, because of the ones that failed. This study looked at a single approved drug for 10 companies that got approved cancer drugs and got 650M average. Where did the $3B go, there must be 50 other drugs that failed to make up the difference, these 10 got lucky, 50 others didn't. Which is why that $3B per approved drug is important, it is how much BP (at minimum) is spending for each successful drug which carries some weight of the failures along the way.
https://www.npr.org/sections/health-shots/201...tudy-finds
The actual cost of the drug is less, because of the ones that failed. This study looked at a single approved drug for 10 companies that got approved cancer drugs and got 650M average. Where did the $3B go, there must be 50 other drugs that failed to make up the difference, these 10 got lucky, 50 others didn't. Which is why that $3B per approved drug is important, it is how much BP (at minimum) is spending for each successful drug which carries some weight of the failures along the way.
https://www.npr.org/sections/health-shots/201...tudy-finds
Quote:
One challenge to accurately estimating a company's cost of research and development is putting a dollar amount on the cost of failures. Pharmaceutical companies often spend hundreds of millions of dollars on potential drugs only to discover that they don't work or aren't safe. It's a risky business, so the winners have to pay for the many losers that companies spend money on along the way.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼